购物车
- 全部删除
- 您的购物车当前为空
Avotaciclib trihydrochloride, also known as BEY1107, is a highly effective and orally active inhibitor of cyclin dependent kinase 1 (CDK1). This compound is particularly valuable for researching locally advanced or metastatic pancreatic cancer.
Avotaciclib trihydrochloride, also known as BEY1107, is a highly effective and orally active inhibitor of cyclin dependent kinase 1 (CDK1). This compound is particularly valuable for researching locally advanced or metastatic pancreatic cancer.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
25 mg | ¥ 10,600 | 1-2周 |
产品描述 | Avotaciclib trihydrochloride, also known as BEY1107, is a highly effective and orally active inhibitor of cyclin dependent kinase 1 (CDK1). This compound is particularly valuable for researching locally advanced or metastatic pancreatic cancer. |
别名 | BEY1107 trihydrochloride |
分子量 | 390.65 |
分子式 | C13H14Cl3N7O |
CAS No. | 1983984-01-5 |
密度 | no data available |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容